Related Experiment Video
Updated: Mar 5, 2026
16:56
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
17.7K
A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice
David I Bernstein1, Jose A Bardelas2, Bodil Svanholm Fogh3
1a Bernstein Clinical Research Center and Department of Medicine and Environmental Health , University of Cincinnati , Cincinnati , OH , USA.
Postgraduate Medicine
|March 23, 2017
Summary
Sublingual immunotherapy (SLIT)-tablets are safe and well-tolerated for treating allergic rhinoconjunctivitis and asthma. Most adverse events are mild oral reactions, with serious reactions being rare and manageable.
Area of Science:
- Allergy and Immunology
- Pharmacology
- Clinical Medicine
Background:
- Allergy immunotherapy, including sublingual immunotherapy (SLIT)-tablets, effectively treats allergic rhinoconjunctivitis and associated comorbidities like asthma.
- SLIT-tablets offer a convenient, self-administered option for allergy immunotherapy after initial medical supervision.
- Potential local and rare systemic allergic reactions necessitate understanding the safety and tolerability profile of SLIT-tablets.
Purpose of the Study:
- To inform healthcare practitioners about the safety and tolerability of SLIT-tablets.
- To provide practical guidance for managing potential adverse reactions associated with SLIT-tablet therapy.
- To educate patients on expected adverse reactions and their management.
Main Methods:
- Pooled safety data from randomized, multicenter, double-blind, placebo-controlled phase 2 and 3 trials.
- Inclusion of trials for timothy grass, short ragweed, and SQ house dust mite SLIT-tablets.
- Characterization of safety and tolerability profiles based on collected data.
Main Results:
- SLIT-tablets demonstrate a generally favorable safety and tolerability profile.
- No life-threatening events, serious systemic allergic reactions, or airway compromise were reported.
- Common adverse events include transient oral site reactions; systemic reactions are uncommon and manageable with conventional pharmacotherapy.
Conclusions:
- Healthcare providers can use this information to educate patients on SLIT-tablet safety and tolerability.
- Practical guidance is provided for effective management of any adverse reactions.
- SLIT-tablets offer a safe and manageable treatment option for allergic conditions.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
973
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
973
01:30Drug Toxicity: Allergic Reactions
75
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
75
01:26Pharmaceutical Poisoning: Potential Scenarios
47
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
01:30Allergic Reactions: Anaphylaxis
92
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
92
01:27Insulin Formulations: Types and Delivery
893
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
893